Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.

× No keyword cloud information.

14 in total

1. The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Authors: G D Tan; B A Fielding; J M Currie; S M Humphreys; M Désage; K N Frayn; M Laville; H Vidal; F Karpe
Journal: Diabetologia Date: 2004-12-24 Impact factor: 10.122

Review 2. Management of type 2 diabetes mellitus. Role of thiazolidinediones.

Authors: Jason Noble; Mark O Baerlocher; Jay Silverberg
Journal: Can Fam Physician Date: 2005-05 Impact factor: 3.275

Review 3. Current therapeutic options in type 2 diabetes mellitus: a practical approach.

Authors: Michael T Sheehan
Journal: Clin Med Res Date: 2003-07

Review 4. Pioglitazone.

Authors: P S Gillies; C J Dunn
Journal: Drugs Date: 2000-08 Impact factor: 9.546

Review 5. Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.

Authors: Annaswamy Raji; Jorge Plutzky
Journal: Curr Cardiol Rep Date: 2002-11 Impact factor: 2.931

Review 6. Impact of thiazolidenediones on serum lipoprotein levels.

Authors: Ronald B Goldberg
Journal: Curr Atheroscler Rep Date: 2006-09 Impact factor: 5.113

7. Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.

Authors: P D Home; S J Pocock; H Beck-Nielsen; R Gomis; M Hanefeld; H Dargie; M Komajda; J Gubb; N Biswas; N P Jones
Journal: Diabetologia Date: 2005-07-16 Impact factor: 10.122

8. A comparative study on the effects of diet and exercise, metformin and metformin+pioglitazone treatment on NIDDM patients.

Authors: K T Augusti; N P Sunil; Andrews Abraham; Sajimon Thomas; Varghese Chemmanam
Journal: Indian J Clin Biochem Date: 2007-09

Review 9. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.

Authors: Michaela Diamant; Robert J Heine
Journal: Drugs Date: 2003 Impact factor: 9.546

10. miR-30a targets gene networks that promote browning of human and mouse adipocytes.

Authors: Pradip K Saha; Mark P Hamilton; Kimal Rajapakshe; Vasanta Putluri; Jessica B Felix; Peter Masschelin; Aaron R Cox; Mandeep Bajaj; Nagireddy Putluri; Cristian Coarfa; Sean M Hartig
Journal: Am J Physiol Endocrinol Metab Date: 2020-08-17 Impact factor: 4.310